{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06347822",
            "orgStudyIdInfo": {
                "id": "23-011276"
            },
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "Increasing Access to Evidence-Based Care in Integrated Behavioral Health",
            "officialTitle": "Implementation of Single Session Interventions in Integrated Behavioral Health: Increasing Access to Evidence-based Care",
            "therapeuticArea": [
                "Other"
            ],
            "study": "increasing-access-to-evidence-based-care-in-integrated-behavioral-health"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-11",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-22",
            "studyFirstSubmitQcDate": "2024-03-29",
            "studyFirstPostDateStruct": {
                "date": "2024-04-04",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-05",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-08",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Anne I. Roche",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Mayo Clinic"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this research is to explore whether a single-session therapy visit may be of interest to patients seeking mental health services in Mayo Clinic's Integrated Behavioral Health program and whether a single-session therapy visit may be helpful in improving mental health. Researchers hope to better understand whether single-session visits could be a helpful option to offer patients in the future."
        },
        "conditionsModule": {
            "conditions": [
                "Psychotherapy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 34,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Single-Session Therapy Visit",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects will have a single-session therapy visit with an Integrated Behavioral Health (IBH) clinician.",
                    "interventionNames": [
                        "Behavioral: Therapy Session"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Therapy Session",
                    "description": "Single-session intervention (SSI) based on acceptance and commitment therapy (ACT) and solution-focused brief therapy (SFBT) principles",
                    "armGroupLabels": [
                        "Single-Session Therapy Visit"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Satisfaction with IBH therapy",
                    "description": "Measured using the Client Satisfaction Questionnaire-8 (CSQ-8). Total scores range from 8 to 32, with higher number indicating greater satisfaction.",
                    "timeFrame": "Immediately post-intervention (1-1.25 hours after study visit initiation)"
                },
                {
                    "measure": "Satisfaction with Action Plan",
                    "description": "We will use 3 items rated on a five-point scale (0 = not at all, 4 = very much) to assess participant satisfaction with their Action Plan (\"Did the visit help you develop an action plan?\"; \"How hopeful are you that the action plan will be useful?\" and \"How motivated do you feel to use your action plan?\"). Scores will range from 0-12 with higher scores indicating greater satisfaction with the Action Plan.",
                    "timeFrame": "Immediately post-intervention (1-1.25 hours after study visit initiation)"
                },
                {
                    "measure": "Change in readiness for change scores",
                    "description": "The readiness for change ruler is a 3 item measure that examines participant's willingness to change to improve their mental health on a 0 (not at all confident/important/ready) to 10 scale (completely confident/important/ready). The total score ranges from 0 to 30, with higher scores indicating higher levels of willingness to change.",
                    "timeFrame": "Baseline and immediately post-intervention (1-1.25 hours after study visit initiation)"
                },
                {
                    "measure": "Change in belief in capacity to generate routes to reach goals (pathways)",
                    "description": "The State Hope Scale (Pathways subscale) is a 3 item measure that assesses participant belief in their capacity to generate routes to reach goals. Scale responses range from 1 (Definitely false) to 8 (Definitely true), with total scores ranging from 3-24 and higher scores indicating higher levels of pathways thinking.",
                    "timeFrame": "Baseline and immediately post-intervention (1-1.25 hours after study visit initiation)"
                },
                {
                    "measure": "Change in PHQ-9 scores",
                    "description": "The PHQ-9 asks participants to rate 9 questions assessing dimensions of depression on a scale of 0 (Not at all) to 3 (Nearly every day). Total score ranges from 0 to 27 with higher scores indicating higher levels of depression.",
                    "timeFrame": "Baseline and 2-week follow-up"
                },
                {
                    "measure": "Change in GAD-7 scores",
                    "description": "The GAD-7 asks participants to rate 7 statements based on how generally anxious they have felt over the past 2 weeks on a 4 point scale ranging from 0 (Not at all) to 3 (Nearly every day). Total score ranges from 0 to 21 with higher scores representing higher generalized anxiety.",
                    "timeFrame": "Baseline and 2-week follow-up"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in Valuing Questionnaire (Values Progress subscale)",
                    "description": "The 10-item Valuing Questionnaire asks participants to rate statements about valued living on a 7-point Likert-type scale ranging from 0 (not at all true) to 6 (completely true). The measure assesses two subscales, Values Progress (0-30) and Values Obstruction (0-30), with higher scores on each indicating greater values progress and obstruction, respectively.",
                    "timeFrame": "Baseline and 2-week follow-up"
                },
                {
                    "measure": "Change in Valuing Questionnaire (Values Obstruction subscale)",
                    "description": "The 10-item Valuing Questionnaire asks participants to rate statements about valued living on a 7-point Likert-type scale ranging from 0 (not at all true) to 6 (completely true). The measure assesses two subscales, Values Progress (0-30) and Values Obstruction (0-30), with higher scores on each indicating greater values progress and obstruction, respectively.",
                    "timeFrame": "Baseline and 2-week follow-up"
                },
                {
                    "measure": "Change in CompACT scores (Valued Action)",
                    "description": "The Comprehensive Assessment of Acceptance and Commitment Therapy Processes-15 item (CompACT) is used to assess psychological flexibility (three subscales of openness to experience, behavioral awareness, and valued action). Each item is rated on a scale of 0 to 6 (0 = strongly disagree, 6 = strongly agree). Higher scores on each subscale (VA, OE, BA) indicate greater valued action (VA), greater openness to experience (OE), and greater behavioral awareness (BA), respectively.",
                    "timeFrame": "Baseline and 2-week follow-up"
                },
                {
                    "measure": "Change in CompACT scores (Openness to Experience)",
                    "description": "The Comprehensive Assessment of Acceptance and Commitment Therapy Processes-15 item (CompACT) is used to assess psychological flexibility (three subscales of openness to experience, behavioral awareness, and valued action). Each item is rated on a scale of 0 to 6 (0 = strongly disagree, 6 = strongly agree). Higher scores on each subscale (VA, OE, BA) indicate greater valued action (VA), greater openness to experience (OE), and greater behavioral awareness (BA), respectively.",
                    "timeFrame": "Baseline and 2-week follow-up"
                },
                {
                    "measure": "Change in CompACT scores (Behavioral Awareness)",
                    "description": "The Comprehensive Assessment of Acceptance and Commitment Therapy Processes-15 item (CompACT) is used to assess psychological flexibility (three subscales of openness to experience, behavioral awareness, and valued action). Each item is rated on a scale of 0 to 6 (0 = strongly disagree, 6 = strongly agree). Higher scores on each subscale (VA, OE, BA) indicate greater valued action (VA), greater openness to experience (OE), and greater behavioral awareness (BA), respectively.",
                    "timeFrame": "Baseline and 2-week follow-up"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Being a patient currently scheduled for an IBH consultation session at Mayo Clinic Rochester.\n* Able to read and speak English.\n\nExclusion Criteria:\n\n* Individuals diagnosed with psychotic spectrum, Bipolar I and II, or severe substance use disorder and individuals with severe cognitive impairment per chart review will not be eligible and will not be contacted about the study. Individuals must score \u2265 5 on the PHQ-9 and/or GAD-7 but not \\>14 on either measure (indicating mild to moderate depression and/or anxiety) and respond \\< 2 to Item 9 of the PHQ-9 (\"thoughts that you would be better off dead, or thoughts of hurting yourself in some way\") to be eligible for the study.\n* Patients who are ineligible will remain scheduled for a regular IBH therapy consultation as originally planned.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "overallOfficials": [
                {
                    "name": "Anne Roche, PhD",
                    "affiliation": "Mayo Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic in Rochester",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Anne Roche, PhD",
                            "role": "CONTACT",
                            "phone": "507-284-0592",
                            "email": "roche.anne@mayo.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}